Molecular Profiling Distinguishes Papillary Carcinoma from Benign Thyroid Nodules
David J. Finley,
Nimmi Arora,
Baixin Zhu,
Lisa Gallagher and
Thomas J. Fahey, III
Departments of Surgery (D.J.F., N.A., B.Z., T.J.F.) and Pathology (L.G.), Weill Medical College of Cornell University; and Strang Cancer Prevention Center (T.J.F.), New York, New York 10021
Address all correspondence and requests for reprints to: Dr. Thomas J. Fahey III, New York Presbyterian Hospital-Cornell University, Room F-2024, 525 East 68th Street, New York, New York 10021. E-mail: tjfahey{at}mail.med.cornell.edu.
Recently we identified a molecular basis for differentiatingbenign and malignant follicular thyroid tumors. The purposeof these studies was to determine whether molecular analysiscan be used to differentiate papillary thyroid carcinomas frombenign thyroid nodules. Gene expression patterns of 14 papillarythyroid carcinomas and 21 benign tumors were analyzed by oligonucleotidearray analysis. The carcinomas included seven classical papillarythyroid carcinomas (PTC) and seven follicular variant of PTC(FVPTC), and the benign tumors included 14 follicular adenomasand seven hyperplastic nodules. A hierarchical clustering analysiswas performed to examine the groups for potential differences.The combined PTC and FVPTC groups had a distinct gene expressionprofile compared with the benign lesions. The sensitivity fora diagnosis of carcinoma was 93%, with a 100% specificity (oneFVPTC clustered with the benign nodules). Cancer gene profilescontained both known (Met and galectin-3) and previously unidentifiedgenes. Gene profiling is a reliable means of distinguishingPTC, FVPTC, and benign tumors of the thyroid. These gene profilesmay provide insight into the pathogenesis of papillary thyroidcarcinoma and may ultimately enhance the preoperative diagnosisof thyroid nodules on a molecular basis.
This work was supported by a G. Tom Shires Faculty Scholar Award.
M P Menon and A Khan Micro-RNAs in thyroid neoplasms: molecular, diagnostic and therapeutic implications
J. Clin. Pathol.,
November 1, 2009;
62(11):
978 - 985.
[Abstract][Full Text][PDF]
S. Durand, C. Ferraro-Peyret, M. Joufre, A. Chave, F. Borson-Chazot, S. Selmi-Ruby, and B. Rousset Molecular characteristics of papillary thyroid carcinomas without BRAF mutation or RET/PTC rearrangement: relationship with clinico-pathological features
Endocr. Relat. Cancer,
June 1, 2009;
16(2):
467 - 481.
[Abstract][Full Text][PDF]
R. C Smallridge, L. A Marlow, and J. A Copland Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies
Endocr. Relat. Cancer,
March 1, 2009;
16(1):
17 - 44.
[Abstract][Full Text][PDF]
S. Durand, C. Ferraro-Peyret, S. Selmi-Ruby, C. Paulin, M. El Atifi, F. Berger, N. Berger-Dutrieux, M. Decaussin, J.-L. Peix, C. Bournaud, et al. Evaluation of Gene Expression Profiles in Thyroid Nodule Biopsy Material to Diagnose Thyroid Cancer
J. Clin. Endocrinol. Metab.,
April 1, 2008;
93(4):
1195 - 1202.
[Abstract][Full Text][PDF]
G. Riesco-Eizaguirre and P. Santisteban New insights in thyroid follicular cell biology and its impact in thyroid cancer therapy
Endocr. Relat. Cancer,
December 1, 2007;
14(4):
957 - 977.
[Abstract][Full Text][PDF]
K. Fujarewicz, M. Jarzab, M. Eszlinger, K. Krohn, R. Paschke, M. Oczko-Wojciechowska, M. Wiench, A. Kukulska, B. Jarzab, and A. Swierniak A multi-gene approach to differentiate papillary thyroid carcinoma from benign lesions: gene selection using support vector machines with bootstrapping
Endocr. Relat. Cancer,
September 1, 2007;
14(3):
809 - 826.
[Abstract][Full Text][PDF]
M. Eszlinger, K. Krohn, A. Kukulska, B. Jarzab, and R. Paschke Perspectives and Limitations of Microarray-Based Gene Expression Profiling of Thyroid Tumors
Endocr. Rev.,
May 1, 2007;
28(3):
322 - 338.
[Abstract][Full Text][PDF]
M. Yehuda, R. J. Payne, R. M. Seaberg, C. MacMillan, and J. L. Freeman Fine-Needle Aspiration Biopsy of the Thyroid: Atypical Cytopathological Features
Arch Otolaryngol Head Neck Surg,
May 1, 2007;
133(5):
477 - 480.
[Abstract][Full Text][PDF]
O. L. Griffith, A. Melck, S. J.M. Jones, and S. M. Wiseman Meta-Analysis and Meta-Review of Thyroid Cancer Gene Expression Profiling Studies Identifies Important Diagnostic Biomarkers
J. Clin. Oncol.,
November 1, 2006;
24(31):
5043 - 5051.
[Abstract][Full Text][PDF]
M Niedziela Pathogenesis, diagnosis and management of thyroid nodules in children.
Endocr. Relat. Cancer,
June 1, 2006;
13(2):
427 - 453.
[Abstract][Full Text][PDF]
M. Eszlinger, M. Wiench, B. Jarzab, K. Krohn, M. Beck, J. Lauter, E. Gubala, K. Fujarewicz, A. Swierniak, and R. Paschke Meta- and Reanalysis of Gene Expression Profiles of Hot and Cold Thyroid Nodules and Papillary Thyroid Carcinoma for Gene Groups
J. Clin. Endocrinol. Metab.,
May 1, 2006;
91(5):
1934 - 1942.
[Abstract][Full Text][PDF]
B Jarzab, D Handkiewicz-Junak, and J Wloch Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review
Endocr. Relat. Cancer,
December 1, 2005;
12(4):
773 - 803.
[Abstract][Full Text][PDF]
F. Weber, L. Shen, M. A. Aldred, C. D. Morrison, A. Frilling, M. Saji, F. Schuppert, C. E. Broelsch, M. D. Ringel, and C. Eng Genetic Classification of Benign and Malignant Thyroid Follicular Neoplasia Based on a Three-Gene Combination
J. Clin. Endocrinol. Metab.,
May 1, 2005;
90(5):
2512 - 2521.
[Abstract][Full Text][PDF]
B. Jarzab, M. Wiench, K. Fujarewicz, K. Simek, M. Jarzab, M. Oczko-Wojciechowska, J. Wloch, A. Czarniecka, E. Chmielik, D. Lange, et al. Gene Expression Profile of Papillary Thyroid Cancer: Sources of Variability and Diagnostic Implications
Cancer Res.,
February 15, 2005;
65(4):
1587 - 1597.
[Abstract][Full Text][PDF]